{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:58:00Z","timestamp":1791932280657,"version":"4.3.4"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the use of validated guidelines in the management of mild traumatic brain injury (mTBI), processes to limit unnecessary brain scans are still not sufficient and need to be improved. The use of blood biomarkers represents a relevant adjunct to identify patients at risk for intracranial injury requiring computed tomography (CT) scan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>Biomarkers currently recommended in the management of mTBI in adults and children are discussed in this review. Protein S100 beta (S100B) is the best-documented blood biomarker due to its validation in large observational and interventional studies. Glial fibrillary acidic protein (GFAP) and ubiquitin carboxyterminal hydrolase L-1 (UCH-L1) have also recently demonstrated their usefulness in patients with mTBI. Preanalytical, analytical, and postanalytical performance are presented to aid in their interpretation in clinical practice. Finally, new perspectives on biomarkers and mTBI are discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>In adults, the inclusion of S100B in Scandinavian and French guidelines has reduced the need for CT scans by at least 30%. S100B has significant potential as a diagnostic biomarker, but limitations include its rapid half-life, which requires blood collection within 3\u2005h of trauma, and its lack of neurospecificity. In 2018, the FDA approved the use of combined determination of GFAP and UCH-L1 to aid in the assessment of mTBI. Since 2022, new French guidelines also recommend the determination of GFAP and UCH-L1 in order to target a larger number of patients (sampling within 12\u2005h post-injury) and optimize the reduction of CT scans. In the future, new cut-offs related to age and promising new biomarkers are expected for both diagnostic and prognostic applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvae049","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T19:20:08Z","timestamp":1711048808000},"page":"1023-1036","source":"Crossref","is-referenced-by-count":41,"title":["Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice"],"prefix":"10.1093","volume":"70","author":[{"given":"Charlotte","family":"Oris","sequence":"first","affiliation":[{"name":"Biochemistry and Molecular Genetics Department, CHU Clermont-Ferrand , 63000 Clermont-Ferrand , France"},{"name":"CNRS, INSERM, iGReD, Clermont Auvergne University , Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5918-1315","authenticated-orcid":false,"given":"Samy","family":"Kahouadji","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Department, CHU Clermont-Ferrand , 63000 Clermont-Ferrand , France"},{"name":"CNRS, INSERM, iGReD, Clermont Auvergne University , Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-4320","authenticated-orcid":false,"given":"Damien","family":"Bouvier","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Department, CHU Clermont-Ferrand , 63000 Clermont-Ferrand , France"},{"name":"CNRS, INSERM, iGReD, Clermont Auvergne University , Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-315X","authenticated-orcid":false,"given":"Vincent","family":"Sapin","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Department, CHU Clermont-Ferrand , 63000 Clermont-Ferrand , France"},{"name":"CNRS, INSERM, iGReD, Clermont Auvergne University , Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2024080108453964000_hvae049-B1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J Neurosurg"},{"key":"2024080108453964000_hvae049-B2","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3390\/ijms24076602","article-title":"S100b, actor and biomarker of mild traumatic brain injury","volume":"24","author":"Oris","year":"2023","journal-title":"IJMS"},{"key":"2024080108453964000_hvae049-B3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0037","article-title":"The biomarker S100B and mild traumatic brain injury: a meta-analysis","volume":"141","author":"Oris","year":"2018","journal-title":"Pediatrics"},{"key":"2024080108453964000_hvae049-B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13049-019-0673-8","article-title":"Application of NICE or SNC guidelines may reduce the need for computerized tomographies in patients with mild traumatic brain injury: a retrospective chart review and theoretical application of five guidelines","volume":"27","author":"Svensson","year":"2019","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2024080108453964000_hvae049-B5","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/S0140-6736(17)30555-X","article-title":"Accuracy of PECARN, CATCH, and CHALICE head injury decision rules in children: a prospective cohort study","volume":"389","author":"Babl","year":"2017","journal-title":"Lancet"},{"key":"2024080108453964000_hvae049-B6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","article-title":"A soluble protein characteristic of the nervous system","volume":"19","author":"Moore","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"key":"2024080108453964000_hvae049-B7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","article-title":"The S100 protein family: history, function, and expression","volume":"37","author":"Zimmer","year":"1995","journal-title":"Brain Res Bull"},{"key":"2024080108453964000_hvae049-B8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.14574","article-title":"The S100B story: from biomarker to active factor in neural injury","volume":"148","author":"Michetti","year":"2019","journal-title":"J Neurochem"},{"key":"2024080108453964000_hvae049-B9","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.3390\/ijms23169138","article-title":"Glymphatic system a window on TBI pathophysiology: a systematic review","volume":"23","author":"Ferrara","year":"2022","journal-title":"IJMS"},{"key":"2024080108453964000_hvae049-B10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1515\/cclm-2018-1217","article-title":"Measurement of S100B protein: evaluation of a new prototype on a bioM\u00e9rieux Vidas\u00ae 3 analyzer","volume":"57","author":"Oris","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0771","article-title":"Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays","volume":"54","author":"Bouvier","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/HTR.0b013e3181e57e22","article-title":"Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis","volume":"25","author":"Und\u00e9n","year":"2010","journal-title":"J Head Trauma Rehabil"},{"key":"2024080108453964000_hvae049-B13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.clinbiochem.2011.05.004","article-title":"Reference ranges for serum S100B protein during the first three years of life","volume":"44","author":"Bouvier","year":"2011","journal-title":"Clin Biochem"},{"key":"2024080108453964000_hvae049-B14","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1515\/cclm-2018-0471","article-title":"Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients","volume":"56","author":"Allouchery","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/gerona\/glab055","article-title":"Predictive performance of blood S100B in the management of patients over 65 years old with mild traumatic brain injury","volume":"76","author":"Oris","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024080108453964000_hvae049-B16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1373\/49.5.836","article-title":"Reference values for serum S-100B protein depend on the race of individuals","volume":"49","author":"Ben Abdesselam","year":"2003","journal-title":"Clin Chem"},{"key":"2024080108453964000_hvae049-B17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.injury.2020.03.012","article-title":"Increased S-100 B levels are associated with fractures and soft tissue injury in multiple trauma patients","volume":"51","author":"M\u00fcller","year":"2020","journal-title":"Injury"},{"key":"2024080108453964000_hvae049-B18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4085\/1062-6050-49.3.33","article-title":"A systematic review of the biomarker S100B: implications for sport-related concussion management","volume":"49","author":"Schulte","year":"2014","journal-title":"J Athl Train"},{"key":"2024080108453964000_hvae049-B19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.shk.0000209534.61058.35","article-title":"Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study","volume":"25","author":"Biberthaler","year":"2006","journal-title":"Shock"},{"key":"2024080108453964000_hvae049-B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-227X-12-13","article-title":"Clinical validation of S100B use in management of mild head injury","volume":"12","author":"Calcagnile","year":"2012","journal-title":"BMC Emerg Med"},{"key":"2024080108453964000_hvae049-B21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12916-015-0533-y","article-title":"Validation of the scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults","volume":"13","author":"Und\u00e9n","year":"2015","journal-title":"BMC Med"},{"key":"2024080108453964000_hvae049-B22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12883-016-0723-z","article-title":"The addition of S100B to guidelines for management of mild head injury is potentially cost saving","volume":"16","author":"Calcagnile","year":"2016","journal-title":"BMC Neurol"},{"key":"2024080108453964000_hvae049-B23","author":"Gil-Jardin\u00e9"},{"key":"2024080108453964000_hvae049-B24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/cclm-2013-0621","article-title":"S100b blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study","volume":"52","author":"Laribi","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1515\/cclm-2020-1293","article-title":"Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury","volume":"59","author":"Lorton","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B26","doi-asserted-by":"crossref","first-page":"e027365","DOI":"10.1136\/bmjopen-2018-027365","article-title":"Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury\u2014PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial","volume":"9","author":"Bouvier","year":"2019","journal-title":"BMJ Open"},{"key":"2024080108453964000_hvae049-B27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog Neurobiol"},{"key":"2024080108453964000_hvae049-B28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuchi.2021.01.001","article-title":"Blood biomarkers of mild traumatic brain injury: state of art","volume":"67","author":"Sapin","year":"2021","journal-title":"Neurochirurgie"},{"key":"2024080108453964000_hvae049-B29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"2024080108453964000_hvae049-B30","doi-asserted-by":"crossref","first-page":"668606","DOI":"10.3389\/fneur.2021.668606","article-title":"A kinetic model for blood biomarker levels after mild traumatic brain injury","volume":"12","author":"Azizi","year":"2021","journal-title":"Front Neurol"},{"key":"2024080108453964000_hvae049-B31","doi-asserted-by":"crossref","first-page":"e2252387","DOI":"10.1001\/jamanetworkopen.2022.52387","article-title":"Association of kidney function with development of Alzheimer disease and other dementias and dementia-related blood biomarkers","volume":"6","author":"Stocker","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024080108453964000_hvae049-B32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fneur.2017.00300","article-title":"Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review","volume":"8","author":"Thelin","year":"2017","journal-title":"Front Neurol"},{"key":"2024080108453964000_hvae049-B33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0022-510X(81)90032-0","article-title":"The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis","volume":"49","author":"Jackson","year":"1981","journal-title":"J Neurol Sci"},{"key":"2024080108453964000_hvae049-B34","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1042\/BCJ20160082","article-title":"Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction","volume":"473","author":"Bishop","year":"2016","journal-title":"Biochem J"},{"key":"2024080108453964000_hvae049-B35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14728222.2017.1321635","article-title":"Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"2024080108453964000_hvae049-B36","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.3390\/ijms21113910","article-title":"Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): potential mediators for cancer and neurodegeneration","volume":"21","author":"Sharma","year":"2020","journal-title":"IJMS"},{"key":"2024080108453964000_hvae049-B37","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/neu.2018.6053","article-title":"Stability of blood biomarkers of traumatic brain injury","volume":"36","author":"Rezaii","year":"2019","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1515\/cclm-2022-0646","article-title":"Serum GFAP\u2014reference interval and preanalytical properties in Danish adults","volume":"60","author":"Tybirk","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/bios11090319","article-title":"The current state of traumatic brain injury biomarker measurement methods","volume":"11","author":"Krausz","year":"2021","journal-title":"Biosensors"},{"key":"2024080108453964000_hvae049-B40","doi-asserted-by":"crossref","first-page":"28203","DOI":"10.1038\/srep28203","article-title":"Serum concentrations of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein after pediatric traumatic brain injury","volume":"6","author":"Mondello","year":"2016","journal-title":"Sci Rep"},{"key":"2024080108453964000_hvae049-B41","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1515\/cclm-2023-0280","article-title":"Serum GFAP\u2014pediatric reference interval in a cohort of Danish children","volume":"61","author":"Tybirk","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B42","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.annemergmed.2011.06.133","article-title":"106 neuronal biomarkers may require age-adjusted norms","volume":"58","author":"Ferguson","year":"2011","journal-title":"Ann Emerg Med"},{"key":"2024080108453964000_hvae049-B43","doi-asserted-by":"crossref","first-page":"e000473","DOI":"10.1136\/bmjpo-2019-000473","article-title":"Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study","volume":"3","author":"Papa","year":"2019","journal-title":"BMJ Paediatr Open"},{"key":"2024080108453964000_hvae049-B44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/neu.2015.3869","article-title":"In children and youth with mild and moderate traumatic brain injury, glial fibrillary acidic protein out-performs S100\u03b2 in detecting traumatic intracranial lesions on computed tomography","volume":"33","author":"Papa","year":"2016","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B45","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.TA.0000108998.48026.C3","article-title":"Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma","volume":"57","author":"Pelinka","year":"2004","journal-title":"J Trauma"},{"key":"2024080108453964000_hvae049-B46","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1089\/neu.2013.3245","article-title":"GFAP out-performs S100\u03b2 in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions","volume":"31","author":"Papa","year":"2014","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B47","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/acem.14366","article-title":"Accuracy of a rapid glial fibrillary acidic protein\/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury","volume":"28","author":"Bazarian","year":"2021","journal-title":"Acad Emerg Med"},{"key":"2024080108453964000_hvae049-B48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/neu.2022.0267","article-title":"Effects of physical exertion on early changes in blood-based brain biomarkers: implications for the acute point of care diagnosis of concussion","volume":"40","author":"Bazarian","year":"2023","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.13181\/mji.v25i2.1267","article-title":"Comparison of GFAP and HSP27 concentrations in acute moderate-intensity aerobic exercise of different duration","volume":"25","author":"Stefanus","year":"2016","journal-title":"Med J Indones"},{"key":"2024080108453964000_hvae049-B50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","article-title":"Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention","volume":"59","author":"Papa","year":"2012","journal-title":"Ann Emerg Med"},{"key":"2024080108453964000_hvae049-B51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/TA.0b013e3182491e3d","article-title":"Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention","volume":"72","author":"Papa","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"2024080108453964000_hvae049-B52","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1089\/neu.2016.4806","article-title":"Neuronal biomarker ubiquitin C-terminal hydrolase detects traumatic intracranial lesions on computed tomography in children and youth with mild traumatic brain injury","volume":"34","author":"Papa","year":"2017","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/neu.2015.4149","article-title":"Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury","volume":"33","author":"Welch","year":"2016","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B54","doi-asserted-by":"crossref","first-page":"e0200394","DOI":"10.1371\/journal.pone.0200394","article-title":"Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury","volume":"13","author":"Lagerstedt","year":"2018","journal-title":"PLoS One"},{"key":"2024080108453964000_hvae049-B55","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"key":"2024080108453964000_hvae049-B56","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1089\/neu.2018.6254","article-title":"Correlation of blood biomarkers and biomarker panels with traumatic findings on computed tomography after traumatic brain injury","volume":"36","author":"Posti","year":"2019","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B57","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/neur.2021.0048","article-title":"Evaluation of acute glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 plasma levels in traumatic brain injury patients with and without intracranial lesions","volume":"2","author":"Biberthaler","year":"2021","journal-title":"Neurotrauma Rep"},{"key":"2024080108453964000_hvae049-B59","doi-asserted-by":"crossref","first-page":"e610-22","DOI":"10.1212\/WNL.0000000000009983","article-title":"Neurofilament light as a biomarker in traumatic brain injury","volume":"95","author":"Shahim","year":"2020","journal-title":"Neurology"},{"key":"2024080108453964000_hvae049-B60","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1515\/cclm-2022-0173","article-title":"Evaluation of serum neurofilament light in the early management of mTBI patients","volume":"60","author":"Kahouadji","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2024080108453964000_hvae049-B61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","article-title":"Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review","volume":"132","author":"Visser","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"2024080108453964000_hvae049-B62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2014the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"2024080108453964000_hvae049-B63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1089\/neu.2016.4857","article-title":"MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury","volume":"34","author":"Di Pietro","year":"2017","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B64","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fneur.2020.00528","article-title":"Is salivary S100B a biomarker of traumatic brain injury? A pilot study","volume":"11","author":"Janigro","year":"2020","journal-title":"Front Neurol"},{"key":"2024080108453964000_hvae049-B65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-9-9","article-title":"Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages","volume":"9","author":"L\u00e4sser","year":"2011","journal-title":"J Transl Med"},{"key":"2024080108453964000_hvae049-B66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fneur.2020.00663","article-title":"Extracellular vesicle proteins and MicroRNAs as biomarkers for traumatic brain injury","volume":"11","author":"Guedes","year":"2020","journal-title":"Front Neurol"},{"key":"2024080108453964000_hvae049-B67","doi-asserted-by":"crossref","first-page":"e0284875","DOI":"10.1371\/journal.pone.0284875","article-title":"A standardized method for plasma extracellular vesicle isolation and size distribution analysis","volume":"18","author":"Diehl","year":"2023","journal-title":"PLoS One"},{"key":"2024080108453964000_hvae049-B68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","article-title":"A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury","volume":"159","author":"Thelin","year":"2017","journal-title":"Acta Neurochir"},{"key":"2024080108453964000_hvae049-B69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2016.04.005","article-title":"Early CSF and serum S100B concentrations for outcome prediction in traumatic brain injury and subarachnoid hemorrhage","volume":"145","author":"Kellermann","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"2024080108453964000_hvae049-B70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/neu.2004.21.1553","article-title":"GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome","volume":"21","author":"Pelinka","year":"2004","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","article-title":"Prognostic value of day-of-injury plasma GFAP and UCH-L1 levels for predicting functional recovery in the TRACK-TBI cohort: an observational cohort study","volume":"21","author":"Korley","year":"2022","journal-title":"Lancet Neurol"},{"key":"2024080108453964000_hvae049-B72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol"},{"key":"2024080108453964000_hvae049-B73","doi-asserted-by":"crossref","first-page":"36791","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"key":"2024080108453964000_hvae049-B74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/neu.2022.0148","article-title":"Blood biomarkers for return to play after concussion in professional rugby players","volume":"40","author":"Oris","year":"2023","journal-title":"J Neurotrauma"},{"key":"2024080108453964000_hvae049-B75","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/bjsports-2017-097699","article-title":"Consensus statement on concussion in sport\u2014the 5th international conference on concussion in sport held in Berlin, October 2016","volume":"51","author":"McCrory","year":"2017","journal-title":"Br J Sports Med"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/8\/1023\/58709650\/hvae049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/8\/1023\/58709650\/hvae049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T17:11:47Z","timestamp":1722532307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/70\/8\/1023\/7657608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4,24]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvae049","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,4,24]]}}}